Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Recurrent violence linked to substantially higher rates of mental disorders in post-conflict communities

  • Luck affects how we judge reckless actions

  • Motor skill deficiencies linked to autism severity, reseearch says

  • New ultrasound device may add in detecting risk for heart attack, stroke

  • Leaders call for expanded use of medications to combat opioid overdose epidemic

  • Take notes by hand for better long-term comprehension

  • Paying closer attention to attention

  • Small business owners not always worried about being treated fairly, researcher finds

  • Fruitfly study identifies brain circuit that drives daily cycles of rest, activity

  • New genetic brain disorder in humans discovered

  •